Information

ADDF's Diagnostics Accelerator is a specialized initiative by the Alzheimer's Drug Discovery Foundation (ADDF) aimed at challenging the research community to develop cutting-edge biomarkers for Alzheimer's disease and related dementias. This program seeks to advance the field by providing funding, resources, and support to researchers and organizations working on innovative diagnostic tools. Entrepreneurs and researchers benefit from access to ADDF's extensive network, expert guidance, and potential partnerships, enhancing their ability to bring novel diagnostics to market. The accelerator also offers opportunities for visibility and credibility within the scientific and medical communities.

How to Apply

To apply for ADDF's Diagnostics Accelerator, interested parties should visit the official ADDF website and navigate to the Diagnostics Accelerator section. There, applicants can find detailed information on eligibility criteria, application guidelines, and deadlines. The application process typically involves submitting a comprehensive proposal outlining the project's objectives, methodology, and potential impact. Additionally, applicants may need to provide supporting documentation, such as preliminary data and budget estimates. It is advisable to carefully review all instructions and criteria to ensure a complete and competitive application.

Total number of startups invested: 3

Average Funding: The average funding round varies depending on the project's scope and potential impact. Generally, funding can range from $150,000 to several million dollars.

Industry: Biotechnology, Healthcare, Alzheimer's Disease Research

Market: Global